Prana Biotechnology Limited (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 96   

Articles published

PRAN 0.900 -0.020 (-2.17%)
price chart
Sadif Downgrades Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) As Atlantic ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) has been downgraded to Above Average from Good at Sadif. The analysts have noted some weaknesses in the company and believe that its future could be more challenging than the present.
Prana Biotechnology Stock Surges On Approval
Prana Biotechnology Limited (ADR) (PRAN) is up over 30% during trading today on the back of orphan drug designation for its drug PBT2.
Prana Biotechnology Limited leaps on potential breakthrough: Should you buy?  Motley Fool Australia
Related articles »  
Why Prana Biotech's & Momenta Pharma's Stock Prices Fell Yesterday
Momenta Pharmaceutical (MNTA) was down 16.85% at the closing bell yesterday as Teva Pharmaceutical Industries Ltd. (ADR) (TEVA) got the green light from the Supreme Court, signaling that the court will consider its appeal for extension of the patent on ...
Prana Biotechnology Limited shares crash on trial results  The Motley Fool
Prana Biotech Plunges 76%; Drug Fails in Alzheimer Study  Bloomberg
Related articles »  
Investor News: IsoRay Inc. (NYSEMKT:ISR), Prana Biotechnology Limited (ADR ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) American depositary shares edged higher Monday, as the therapeutic-drugs developer's stock extended a recent climb from its 52-week low.
Prana Biotechnology Limited (ADR) (PRAN) news: Prana Biotechnology - A Gamble ...
One company in particular, Prana Biotechnology (NASDAQ:PRAN), is well-positioned to address this market with their lead drug, and in a realistic but optimistic scenario, the share price could ducuple (increase by 10 times) by the end of the month.
Prana Biotechnology Limited (ADR) (PRAN) news: Prana: Right Drug, Wrong Dose
Prana Biotechnology Limited (NASDAQ:PRAN) is expected to release the results from its Phase 2b IMAGINE trial of PBT2 for the treatment of Alzheimer's disease within the coming month.
Should You Invest In Prana Biotechnology Limited (PRAN), IsoRay, Inc.(ISR) and ...
Prana Biotechnology Limited (ADR)(NASDAQ:PRAN) lost $1.09 to finish the day at a closing price of $1.09. The 33.54% decline in value came on a day when the stock traded for as little as $1.07, a new 52 week low for Melbourne-based biotechnology ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN): The Research Programs Will Go On
Boston, MA, 04/09/2014 (usastockreport) - Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) announces issue of ordinary shares to carry out its business proceeds.
Related articles »  
Why Prana Biotechnology Limited soared 33% today
Biotech company Prana Biotechnology Limited (ASX: PBT) saw its shares soar 33% to 22 cents in trading today, following similar gains (21%) in its NASDAQ-listed shares overnight.
Related articles »  
BEST STOCKS TODAY: AVEO Pharmaceuticals, Inc., Prana Biotechnology Limited ADR ...
OTCFire.com provides it's members with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued, and hidden stocks traded on the NASDAQ, NYSE, AMEX, and OTC Markets with the potential of fast gains.
Prana Biotechnology Limited responds to ASX speeding ticket: What you need ...  Motley Fool Australia